§ PHARMACEUTICALS
USD · PharmaceuticalsTBPH
THERAVANCE BIOPHARMA INC
USDSector · PharmaceuticalsBeta · 0.19
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
105 increased/new, 55 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 7.7 | P/B | 3.20 |
| EPS (TTM) | 2.20 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Madison Avenue Partners, LP | 9.5M | 6.7% | ±0% |
| Newtyn Management, LLC | 4.8M | 8.4% | +13% |
| BlackRock, Inc. | 4.3M | 0.0% | +6% |
| Irenic Capital Management LP | 2.8M | 2.9% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | n/a | n/a |
| State Street | 1.3M | 0.0% | +18% |
◇ AC INTELLIGENCE
Top institutional owners for TBPH as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER72.7% · 107 holders
PASSIVE / INDEX12.4% · 8 holders
DEALER / BANK8.4% · 21 holders
QUALITY / COMPOUNDER5.3% · 13 holders
SYSTEMATIC / QUANT2.3% · 9 holders
ACTIVIST1.9% · 1 holder
INCOME / DEFENSIVE0.7% · 12 holders
TACTICAL / MACRO0.5% · 2 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for TBPH in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention TBPH yet.